Renthyroid Tablet
Product Images NDC 64950-172

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Renthyroid (NDC 64950-172). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Genus Lifesciences, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Liothyronine (Renthyroid 01)

Liothyronine (Renthyroid 01)
Chemical structure of liothyronine (T3), showing its molecular arrangement with iodine atoms, phenol groups, and amino acid components. This diagram represents the active ingredient liothyronine in the RenThyroid tablet formulation.*
FDA Label Image

Levothyroxine (Renthyroid 02)

Levothyroxine (Renthyroid 02)
Chemical structure of Levothyroxine (T4), showing two iodinated aromatic rings connected through an ether linkage to a side chain with an amino group and a carboxyl group.*
FDA Label Image

Principal Display Panel (15 mg Tablet Bottle Label)

Principal Display Panel (15 mg Tablet Bottle Label)
RenThyroid 1/4 grain (15 mg) thyroid tablets label showing the brand name with strength, active ingredients levothyroxine 9.5 mcg and liothyronine 2.25 mcg per tablet. The label indicates a package of 100 tablets for oral use, manufactured by Genus Lifesciences Inc. Directions for use and storage instructions are also included.*
FDA Label Image

Principal Display Panel (30 mg Tablet Bottle Label)

Principal Display Panel (30 mg Tablet Bottle Label)
RenThyroid 30 mg thyroid tablets, USP label displaying dosage strength as 1/2 grain (30 mg). Each tablet contains 19 mcg levothyroxine (T4) and 4.5 mcg liothyronine (T3). The oral tablet package contains 100 tablets and is manufactured by Genus Lifesciences Inc. Directions and storage information are also shown.*
FDA Label Image

Principal Display Panel (45 mg Tablet Bottle Label)

Principal Display Panel (45 mg Tablet Bottle Label)
Label for RenThyroid 3/4 grain (45 mg) thyroid tablets containing levothyroxine 28.5 mcg and liothyronine 6.75 mcg per tablet. The package contains 100 tablets, manufactured by Genus Lifesciences Inc. Directions and storage instructions are also included on the label along with the NDC 64950-179-01 and a barcode.*
FDA Label Image

Principal Display Panel (60 mg Tablet Bottle Label)

Principal Display Panel (60 mg Tablet Bottle Label)
Label for RenThyroid Thyroid Tablets USP containing 1 grain (60 mg) strength. It lists active ingredients as Levothyroxine (38 mcg) and Liothyronine (9 mcg) per tablet. The label shows the product is manufactured by Genus Lifesciences Inc. and is available in a bottle of 100 tablets for oral use, prescription only.*
FDA Label Image

Principal Display Panel (75 mg Tablet Bottle Label)

Principal Display Panel (75 mg Tablet Bottle Label)
RenThyroid Thyroid Tablets USP label showing 1 1/4 grain (75 mg) strength. Each tablet contains 47.5 mcg levothyroxine and 11.25 mcg liothyronine. The label includes directions, storage instructions, and manufacturer information for Genus Lifesciences Inc. The package contains 100 tablets and is Rx only.*
FDA Label Image

Principal Display Panel (90 mg Tablet Bottle Label)

Principal Display Panel (90 mg Tablet Bottle Label)
Label for RenThyroid Thyroid Tablets, USP, 1½ grain (90 mg) strength, oral tablet dosage form. The package contains 100 tablets. Active ingredients per tablet include 57 mcg levothyroxine and 13.5 mcg liothyronine. Manufactured by Genus Lifesciences Inc., Allentown, PA. The label includes storage instructions, a barcode, and prescription-only designation.*
FDA Label Image

Principal Display Panel (120 mg Tablet Bottle Label)

Principal Display Panel (120 mg Tablet Bottle Label)
Label for RenThyroid Thyroid Tablets by Genus Lifesciences, showing strength as 2 grain (120 mg) with each tablet containing 76 mcg Levothyroxine and 18 mcg Liothyronine. Package includes 100 tablets for oral use, with storage and safety instructions noted. The label features the NDC code 64950-174-01 and a barcode.*
FDA Label Image

Principal Display Panel (180 mg Tablet Bottle Label)

Principal Display Panel (180 mg Tablet Bottle Label)
RenThyroid (Levothyroxine and Liothyronine) thyroid tablets, USP, 3 grain (180 mg) oral tablets in a container of 100. The label indicates each tablet contains 114 mcg Levothyroxine and 27 mcg Liothyronine. Manufactured by Genus Lifesciences Inc., Allentown, PA, with directions to store protected from light and moisture.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.